Curanex Pharmaceuticals Inc Common Stock (CURX) — Financial Flexibility Index
Curanex Pharmaceuticals Inc Common Stock (CURX) has a Financial Flexibility Index of -49.40x as of September 2025. Free cash flow of $-9.19 Million (operating CF $-9.19 Million minus capex $0.00) represents -49% of total liabilities ($185.96K). Check how aggressively does Curanex Pharmaceuticals Inc Common Stock reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Curanex Pharmaceuticals Inc Common Stock Financial Flexibility Index (2023–2024)
Historical Financial Flexibility Index trend for Curanex Pharmaceuticals Inc Common Stock across 2 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Curanex Pharmaceuticals Inc Common Stock.
Annual Financial Flexibility Index for Curanex Pharmaceuticals Inc Common Stock (2023–2024)
Year-by-year free cash flow to debt coverage for Curanex Pharmaceuticals Inc Common Stock. Explore Curanex Pharmaceuticals Inc Common Stock (CURX) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -38.12x | $-555.57K | $-555.58K | $14.57K | ▼ -453377.3% |
| 2023 | -0.01x | $-120.00 | $-120.00 | $14.28K | — |